Patents/Assignees

ENDOGENA THERAPEUTICS, Inc.

3 patents in portfolio

US12195452utility2025
N-(4-(oxazol-5-yl)phenyl) Chromane-3-carboxamide Derivatives and Related Compounds as Stimulators of the Production of Retinal Precursor Cells for the Treatment of Neuroretinal Diseases
0 cites
US11844755utility2023
Compounds and Their Use as Therapeutically Active Substances in the Treatment And/or Reducing Signs or Symptoms of Diseases Involving the Retinal Pigment Epithelium
0 cites
US11541039utility2023
Compounds and Their Use as Therapeutically Active Substances in the Treatment And/or Reducing Signs or Symptoms of Diseases Involving the Retinal Pigment Epithelium
0 cites